Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | SUKUN PHARMA | 1 | ₹360 |
| 2 | Schedule 2 | GAURI SHANKAR & COMPANY | 1 | ₹4,120 |
| 3 | Schedule 3 | SRI SAI AGENCIES | 1 | ₹1,380 |
| 4 | Schedule 4 | SUKUN PHARMA | 1 | ₹5,688 |
| 5 | Schedule 5 | SUKUN PHARMA | 1 | ₹371 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
19 Aug 2025, 1:00 pmClosed
Title 1
Title 2
Title 3
Title 4
Title 5
Title 6
Title 7
Title 8
Title 9
Title 10
Title 11
Title 12
Title 13
Title 14
Title 15
Title 16
Title 17
Title 18
Title 19
Title 20
Title 21
Title 22
Title 23
Title 24
Title 25
Title 26
Title 27
Title 28
Title 29
Title 30
Title 31
Title 32
Title 33
Title 34
Title 35
Title 36
Title 37
Title 38
Title 39
Title 40
Title 41
Title 42
Title 43
Title 44
Title 45
Title 46
Title 47
Title 48
Title 49
Title 50
Title 51
Title 52
Title 53
Title 54
Title 55
Title 56
Title 57
Title 58
Title 59
Title 60
Title 61
Title 62
Title 63
Title 64
Title 65
Title 66
Title 67
Title 68
Title 69
Title 70
Title 71
Title 72
Title 73
Title 74
Title 75
Title 76
Title 77
Title 78
Title 79
Title 80
Title 81
Title 82
Title 83
Title 84
Title 85
Title 86
Title 87
Title 88
Title 89
Title 90
Title 91
Title 92
Title 93
Title 94
Title 95
Title 96
Title 97
Title 98
Title 99
Title 100
Title 101
Title 102
Title 103
Title 104
Title 105
Title 106
Title 107
Title 108
Title 109
Title 110
Title 111
Title 112
Title 113
Title 114
Title 115
Title 116
Title 117
Title 118
Title 119
Title 120
Title 121
Title 122
Title 123
Title 124
Title 125
Title 126
Title 127
Title 128
Title 129
Title 130
Title 131
Title 132
Title 133
Title 134
Title 135
Title 136
Title 137
Title 138
Title 139
Title 140
Title 141
Title 142
Title 143
Title 144
Title 145
Title 146
Title 147
Title 148
Title 149
Title 150
Title 151
Title 152
Title 153
Title 154
Title 155
Title 156
Title 157
Title 158
Title 159
Title 160
Title 161
Title 162
Title 163
Title 164
Title 165
Title 166
Title 167
Title 168
Title 169
Title 170
Title 171
Title 172
Title 173
Title 174
Title 175
Title 176
Title 177
Title 178
Title 179
Title 180
Title 181
Title 182
Title 183
Title 184
Title 185
Title 186
Title 187
Title 188
Title 189
Title 190
Title 191
Title 192
Title 193
Title 194
Title 195
Title 196
Title 197
Title 198
8151863
GEM/2025/B/6507873
Two Packet Bid
Title 1
21 days
West Bengal; Bardhaman
Item wise evaluation
BOQ
6 documents required · 6 mandatory
3 yrs
₹7 L
₹30 L
30%
Exempted
19 Aug 2025
30 Jul 2025
19 Aug 2025
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Title 1 | Tab Acebrophylline 200 mg SR | 300 | No | BURDWAN | 21 |
| 2 | Title 2 | Tab Aceclofenac 100 mg + Paracetamol 325 mg + Serratiopeptidase 15 mg | 4,000 | No | BURDWAN | 21 |
| 3 | Title 3 | Tab Acyclovir 200 mg | 1,000 | No | BURDWAN | 21 |
| 4 | Title 4 | Tab Ademetionine 400mg | 600 | No | BURDWAN | 21 |
| 5 | Title 5 | Tab Alendronate Sodium 70mg | 140 | No | BURDWAN | 21 |
| 6 | Title 6 | Tab Alfuzosin 10 mg | 2,000 | No | BURDWAN | 21 |
| 7 | Title 7 | Tab Alprazolam 0.25 mg | 1,500 | No | BURDWAN | 21 |
| 8 | Title 8 | Tab Antispasmodic containing Mefenamic Acid 250 mg & Dicyclomine HCl 10 mg | 4,500 | No | BURDWAN | 21 |
| 9 | Title 9 | Tab Apixaban 2.5 mg | 1,500 | No | BURDWAN | 21 |
| 10 | Title 10 | Tab Aripiprazole 10 mg | 900 | No | BURDWAN | 21 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8151863.pdf
GEM_BID
dglp_boq3_2025-07-29-11-46-29_ffcbbe1765e2affc86c71523db077c44.pdf
BOQ
dglp_boq3_2025-07-29-11-46-29_79e1f92820840a802b21145c286985bd.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .